The short version: copper peptides have been studied in hair follicle biology for decades, and the lab data is genuinely interesting. The human evidence is thin, and claims that GHK-Cu or AHK-Cu “beat minoxidil” are not supported by any head-to-head trial. This review separates what the follicle studies found from what the internet says they found.
A 60-second primer on the hair follicle
Each hair grows from a follicle that cycles through three phases: anagen (growth, lasting years on the scalp), catagen (a short regression phase) and telogen (rest, before the hair sheds). At the base of each follicle sits the dermal papilla, a cluster of specialized cells that sends the signals controlling how long anagen lasts and how thick the hair becomes. Most hair research, including copper-peptide research, focuses on keeping follicles in anagen and keeping dermal papilla cells alive and active.
Why copper peptides entered hair research
Two observations pulled copper peptides into the field. First, GHK-Cu influences extracellular matrix and blood-vessel signalling in skin, and follicles sit inside that matrix and depend on that blood supply. Second, copper itself is a cofactor for enzymes involved in hair pigmentation and structure. Researchers wanted to know whether a molecule that delivers copper and remodels the dermis would affect the follicle too.
What GHK-Cu studies report
Reviews by Pickart and colleagues summarize work reporting that GHK-Cu increased follicle size in animal models and stimulated dermal papilla cells in culture. Its broader activity, including collagen stimulation (Maquart, 1988) and effects on many genes linked to tissue repair (Pickart, 2015 and 2018), provides a plausible mechanism. The limitation is that much of this is indirect: skin and matrix data are being extrapolated to the follicle.
For the full GHK-Cu picture, read our GHK-Cu Canada guide.
What AHK-Cu studies report
AHK-Cu swaps glycine for alanine and has the more direct hair data. Pyo and colleagues (2007, Archives of Pharmacal Research) reported that AHK-Cu promoted elongation of human hair follicles in organ culture and increased proliferation of dermal papilla cells while reducing their programmed cell death. That is a stronger, more follicle-specific result than most GHK-Cu hair claims rest on, but it is still an ex vivo study, not a clinical trial. See AHK-Cu.
| GHK-Cu | AHK-Cu | |
|---|---|---|
| Hair evidence type | Mostly indirect (skin, matrix) + animal | Direct follicle organ culture |
| Strongest overall literature | Collagen, wound, gene expression | Hair follicle biology |
| Controlled human hair trials | Limited | Limited |
“Better than minoxidil”? Checking the claim
Many websites claim copper peptides outperform minoxidil. When you look for the source, you typically find one of three things: an in vitro comparison where both compounds were tested on cells, a small cosmetic study without a proper control group, or no source at all. No large, randomized, head-to-head human trial comparing copper peptides with minoxidil has been published.
Minoxidil, by contrast, is an approved treatment with decades of controlled clinical data. That does not mean copper peptides are useless; it means the comparison is not established. Anyone dealing with hair loss should talk to a dermatologist, who can identify the cause (there are many) and discuss proven options.
How to read hair-peptide claims: ask whether the result came from cells, isolated follicles, animals or people, and whether there was a control group. Most claims stop at the first two.
What is missing from the evidence
- Large controlled human trials with standardized hair counts.
- Head-to-head comparisons with approved treatments.
- Independent replication of the strongest follicle findings.
- Data separating the effect of the peptide from the effect of copper alone.
These gaps are exactly what makes copper peptides an active research topic rather than a settled one.
Frequently asked questions
Cliquez sur une question pour afficher la réponse.
Does GHK-Cu help hair growth?
Animal and cell studies report effects on follicle size and dermal papilla cells, but controlled human trials are limited. The evidence is promising but not established.
Is AHK-Cu better than GHK-Cu for hair research?
AHK-Cu has more direct follicle data, including human follicle organ-culture work. GHK-Cu has the broader skin and collagen literature.
Are copper peptides better than minoxidil?
No head-to-head randomized human trial supports that claim. Minoxidil is an approved treatment with extensive clinical data.
What does the dermal papilla do?
It is a cluster of cells at the base of the follicle that signals how long the growth phase lasts and how thick the hair grows.
Selected references
- Pyo HK, Yoo HG, Won CH, et al. The effect of tripeptide-copper complex on human hair growth in vitro. Arch Pharm Res. 2007;30(7):834–839. PubMed
- Pickart L, Margolina A. Regenerative and protective actions of the GHK-Cu peptide in the light of the new gene data. Int J Mol Sci. 2018;19(7):1987. PubMed
- Maquart FX, et al. Stimulation of collagen synthesis in fibroblast cultures by the tripeptide-copper complex glycyl-L-histidyl-L-lysine-Cu2+. FEBS Lett. 1988;238(2):343–346. PubMed
Related reading
- GHK-Cu side effects: topical vs injected
- GHK-Cu in Canada: research guide
- Wolverine vs GLOW vs KLOW
- How to store peptides
All TrueLabs products are sold for in vitro and laboratory research use only. They are not intended for human or veterinary use, and nothing in this article is medical advice. For hair loss, please see a dermatologist.